Milford, Massachusetts-headquartered Waters Corporation has opened a new Solution Centre in Singapore. Housed in Singapore Science Park II, Waters Solution Centre is equipped with advanced analytical application development and demonstration capabilities and training facilities dedicated to addressing the needs of laboratory scientists throughout South East Asia.
“The scientific challenges our customers face in South East Asia are unique to this part of the world and Waters’ new Solution Centre is designed to address these challenges to ensure our customers are successful. Comprising a team of skilled analytical scientists, many at post-doctoral levels, who will offer technical advice and/ or develop applications to solve analytical issues, the Solution Centre will serve the increasing important markets of South East Asia along with Singapore and Australia,” said Mike Harrington, Vice President Europe and Asia Pacific, Waters Division.
In addition to establishing Waters R&D facility for Engineering in Singapore, the new Waters Solution Centre is an extension of Waters’ commitment to promote R&D in Singapore in support of the development of Singapore’s biomedical sciences sector.
“The opening of Waters Solution Centre marks another milestone in our commitment to Singapore. Singapore is a key strategic location for us in Asia and in particular South East Asia, at two levels – business and talents. Not only does it bring us closer to our customers in this region, Singapore as a research hub is also where international and local research talents and minds gather,” said, Mathieu Laouenan, General Manager, South East Asia & Pacific Operations, Waters Corporation.
The Solution Centre will offer customers the Waters Omics Research Platform Solutions, the best-in class instrumental systems for those in the pharmaceutical and life sciences, food, and clinical research areas. With the world’s growing emphasis on medical care, these solutions will help the medical community in South East Asia realise the promise of personalised medicine with a ‘bench to bedside’ approach to optimising the drug discovery process.
“Through development of applications to address the challenges faced by scientists in this part of the world, Waters hopes to leverage its momentum in food safety analysis and life sciences innovation and expand its capability in traditional medicine research and the development of new tools for the chemical industry,” said Mark Ritchie, Senior Manager of Waters Solution Centre.
The new centre will also be equipped with one of Water’s state-of-the-art separation science and mass spectrometry technology, the ACQUITY Ultra Performance Convergence Chromatography (UPC2). ACQUITY UPC2 is a new category of separations science that is proving to be a reliable complementary chromatography platform with unique workflow, application and environmental impact benefits compared to either liquid or gas chromatography platforms. This revolutionary technology replaces the use of organic solvents with safe, green CO2, while increasing analytical performance.
Customers from all market segments throughout South East Asia are encouraged to contact the Solution Centre to better understand and appreciate the features and benefits of Waters Omics Research Platform Solutions, ACQUITY UPC2 or any of Waters’ advanced separation science and mass spectrometry technologies.
EP News Bureau – Mumbai
- Advertisement -
